Vistagen Therapeutics Statistics
NASDAQ: VTGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.2471-0.0035 (-1.40%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Vistagen Therapeutics by the numbers
Vistagen Therapeutics has a market capitalization of $11.0 million based on 44.38M shares outstanding. With trailing EPS of $-1.66, Vistagen Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.7% below its 50-day average and 49.7% below its 200-day average.
Average daily trading volume is 12.40M shares, or about $3.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VTGN valuation vs. peer median
| Metric | VTGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $10.97M | $11.19M | -2% |
| Avg. volume | 12.40M | 310.86K | +3889% |
Peer median across 8 companies: GTBP, KPRX, BLRX, MDCX, TOVX, APUS, PHIO, GDTC.
Valuation
- Market cap
- $10.97M
- EPS (TTM)
- $-1.66
- Shares outstanding
- 44.38M
Price and trading
- Previous close
- 0.2506
- Open
- 0.2521
- Day range
- 0.2424 – 0.2567
- 52-week range
- 0.20 – 5.14
- 52-week change
- -93.76%
- 50-day moving average
- 0.2592
- 200-day moving average
- 0.4913
- Beta
- —
- Volume
- 771.44K
- Average volume
- 12.40M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2026
Additional statistics
- Market Cap
- 10.97M
- Forward Pe
- -0.16
- Eps
- -1.66
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.14
- Week52 Low
- 0.20
- Avg Volume
- 12.40M
- Shares Outstanding
- 44.38M
- Ma50
- 0.26
- Ma200
- 0.49
- Earnings Date
- Aug 14, 2026
- Pct From52w High
- -95.19%
- Pct From52w Low
- 23.55%